HRT provider censured by UK regulator for ‘systemic failures’ that put patients at risk

Theramex, a UK producer of hormone replacement therapy (HRT) drugs, was censured by regulators for 'systemic failures' including outdated prescribing information and unclear pregnancy warnings. The drug industry's self-regulatory body criticized the company for compliance breaches that endangered patient safety.